Search research articles
Contact Us
Filters
Showing results (311-320 of 484) with videos related to
Page
of 49
Sort By:
The American Journal of Clinical Nutrition
|
October 20, 2023
Criterion validation of nutrient profiling systems: a systematic review and meta-analysis
Eden M Barrett, Habiba Afrin, Mike Rayner, et al.
Journal of Hypertension
|
March 4, 2016
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes
Yoichiro Hirakawa, Hisatomi Arima, Ruth Webster, et al.
Nutrition Journal
|
January 7, 2021
Protocol for a randomized controlled trial to test the acceptability and adherence to 6-months of walnut supplementation in Chinese adults at high risk of cardiovascular disease
Yishu Liu, Nan Li, Ni Yan, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
December 5, 2020
Correction to: Contribution of major food companies and their products to household dietary sodium purchases in Australia
Daisy H Coyle, Maria Shahid, Elizabeth K Dunford, et al.
Diabetologia
|
March 15, 2019
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program
David R Matthews, Qiang Li, Vlado Perkovic, et al.
Indian Pacing and Electrophysiology Journal
|
July 16, 2011
Epidemiology of sudden cardiac death in rural South India - insights from the andhra pradesh rural health initiative
Srinivas R Madhavan, Sathish Reddy, Pradeep K Panuganti, et al.
Stroke
|
April 20, 2021
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis
Zien Zhou, Meg J Jardine, Qiang Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 24, 2020
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program
Brendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
June 25, 2020
Contribution of major food companies and their products to household dietary sodium purchases in Australia
Daisy H Coyle, Maria Shahid, Elizabeth K Dunford, et al.
Diabetes Care
|
December 4, 2014
Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes
Bruce Neal, Vlado Perkovic, Dick de Zeeuw, et al.
Page
of 49
Search research articles
Search
Showing results (311-320 of 484) with videos related to
Sort By:
Page
of 49
The American Journal of Clinical Nutrition
|
October 20, 2023
Criterion validation of nutrient profiling systems: a systematic review and meta-analysis
Eden M Barrett, Habiba Afrin, Mike Rayner, et al.
Journal of Hypertension
|
March 4, 2016
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes
Yoichiro Hirakawa, Hisatomi Arima, Ruth Webster, et al.
Nutrition Journal
|
January 7, 2021
Protocol for a randomized controlled trial to test the acceptability and adherence to 6-months of walnut supplementation in Chinese adults at high risk of cardiovascular disease
Yishu Liu, Nan Li, Ni Yan, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
December 5, 2020
Correction to: Contribution of major food companies and their products to household dietary sodium purchases in Australia
Daisy H Coyle, Maria Shahid, Elizabeth K Dunford, et al.
Diabetologia
|
March 15, 2019
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program
David R Matthews, Qiang Li, Vlado Perkovic, et al.
Indian Pacing and Electrophysiology Journal
|
July 16, 2011
Epidemiology of sudden cardiac death in rural South India - insights from the andhra pradesh rural health initiative
Srinivas R Madhavan, Sathish Reddy, Pradeep K Panuganti, et al.
Stroke
|
April 20, 2021
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis
Zien Zhou, Meg J Jardine, Qiang Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 24, 2020
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program
Brendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
June 25, 2020
Contribution of major food companies and their products to household dietary sodium purchases in Australia
Daisy H Coyle, Maria Shahid, Elizabeth K Dunford, et al.
Diabetes Care
|
December 4, 2014
Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes
Bruce Neal, Vlado Perkovic, Dick de Zeeuw, et al.
Page
of 49